Tien Liang BioTech Co., Ltd.
Informe acción TPEX:4127
Capitalización de mercado: NT$1.6b
Salud financiera de hoja de balance de Tien Liang BioTech
Salud financiera controles de criterios 6/6 Tien Liang BioTech tiene un patrimonio de accionistas total de NT$474.2M y una deuda total de NT$105.0M, lo que sitúa su ratio deuda-patrimonio en 22.1%. Sus activos y pasivos totales son NT$652.4M y NT$178.2M respectivamente. El BAIT de Tien Liang BioTech es de NT$10.1M, por lo que su ratio de cobertura de intereses es de 10.2. Tiene efectivo e inversiones a corto plazo que ascienden a NT$189.4M.
Información clave
22.1%
Ratio deuda-patrimonio
Ratio de cobertura de intereses 10.2x Efectivo NT$189.45m Patrimonio NT$474.18m Total pasivo NT$178.21m Activos totales NT$652.39m
Actualizaciones recientes sobre salud financiera
Mostrar todas las actualizaciones
Now 22% overvalued after recent price rise Oct 25
Now 22% overvalued Aug 28
Upcoming dividend of NT$0.50 per share Aug 20
Second quarter 2024 earnings released: NT$0.08 loss per share (vs NT$0.12 profit in 2Q 2023) Aug 17
First quarter 2024 earnings released: EPS: NT$0.17 (vs NT$0.14 in 1Q 2023) May 19
Investor sentiment deteriorates as stock falls 17% Apr 23
Full year 2023 earnings released: EPS: NT$39.00 (vs NT$1.30 in FY 2022) Apr 02
New minor risk - Share price stability Mar 22
Investor sentiment improves as stock rises 22% Mar 19
Tien Liang BioTech Co., Ltd., Annual General Meeting, Jun 28, 2024 Mar 14
Third quarter 2023 earnings released: NT$0.03 loss per share (vs NT$0.20 profit in 3Q 2022) Nov 15
Second quarter 2023 earnings released: EPS: NT$0.12 (vs NT$0.22 in 2Q 2022) Aug 11
Third quarter 2022 earnings released: EPS: NT$0.20 (vs NT$0.45 in 3Q 2021) Nov 16
Third quarter 2022 earnings released: EPS: NT$0.20 (vs NT$0.45 in 3Q 2021) Nov 13
Investor sentiment deteriorated over the past week Jul 04
Investor sentiment improved over the past week Jun 06
Investor sentiment improved over the past week Apr 18
Full year 2021 earnings released: EPS: NT$1.02 (vs NT$1.13 loss in FY 2020) Mar 30
Second quarter 2021 earnings released: EPS NT$0.26 (vs NT$0.39 loss in 2Q 2020) Aug 18
First quarter 2021 earnings released: NT$0.26 loss per share (vs NT$0.045 loss in 1Q 2020) May 17
Is Tien Liang BioTech (GTSM:4127) Using Too Much Debt? Apr 19
Full year 2020 earnings released: NT$1.13 loss per share (vs NT$1.02 loss in FY 2019) Mar 31
New 90-day low: NT$10.55 Jan 20
Tien Liang BioTech (GTSM:4127) Is Carrying A Fair Bit Of Debt Jan 04
Third quarter 2020 earnings released: NT$0.40 loss per share Nov 14
New 90-day low: NT$10.60 Oct 15
New 90-day low: NT$10.80 Sep 30
New 90-day low - NT$11.45 Sep 14
First half earnings released Aug 16
Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (NT$312.0M) de 4127 superan a sus pasivos a corto plazo (NT$144.1M).
Pasivo a largo plazo: Los activos a corto plazo de 4127 (NT$312.0M) superan a sus pasivos a largo plazo (NT$34.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 4127 tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de 4127 ha pasado de 32.2% a 22.1% en los últimos 5 años.
Cobertura de la deuda: La deuda de 4127 está bien cubierta por el flujo de caja operativo (58.7%).
Cobertura de intereses: Los pagos de intereses de la deuda de 4127 están bien cubiertos por el BAIT (10.2x cobertura).
Descubre empresas con salud financiera Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}